Christopher Broder - Publications

Uniformed Services University of the Health Sciences, Bethesda, MD 
Microbiology Biology

157 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Epstein JH, Anthony SJ, Islam A, Kilpatrick AM, Ali Khan S, Balkey MD, Ross N, Smith I, Zambrana-Torrelio C, Tao Y, Islam A, Quan PL, Olival KJ, Khan MSU, Gurley ES, ... ... Broder CC, et al. Nipah virus dynamics in bats and implications for spillover to humans. Proceedings of the National Academy of Sciences of the United States of America. PMID 33139552 DOI: 10.1073/pnas.2000429117  0.4
2020 Gómez Román R, Wang LF, Lee B, Halpin K, de Wit E, Broder CC, Rahman M, Kristiansen P, Saville M. Nipah@20: Lessons Learned from Another Virus with Pandemic Potential. Msphere. 5. PMID 32641430 DOI: 10.1128/mSphere.00602-20  0.4
2020 Playford EG, Munro T, Mahler SM, Elliott S, Gerometta M, Hoger KL, Jones ML, Griffin P, Lynch KD, Carroll H, El Saadi D, Gilmour ME, Hughes B, Hughes K, Huang E, ... ... Broder CC, et al. Safety, tolerability, pharmacokinetics, and immunogenicity of a human monoclonal antibody targeting the G glycoprotein of henipaviruses in healthy adults: a first-in-human, randomised, controlled, phase 1 study. The Lancet. Infectious Diseases. PMID 32027842 DOI: 10.1016/S1473-3099(19)30634-6  0.4
2019 Prasad AN, Woolsey C, Geisbert JB, Agans KN, Borisevich V, Deer DJ, Mire CE, Cross RW, Fenton KA, Broder CC, Geisbert TW. Resistance of Cynomolgus Monkeys to Nipah and Hendra Virus Disease Is Associated With Cell-Mediated and Humoral Immunity. The Journal of Infectious Diseases. PMID 32022850 DOI: 10.1093/infdis/jiz613  0.32
2019 Mire CE, Chan YP, Borisevich V, Cross RW, Yan L, Agans KN, Dang HV, Veesler D, Fenton KA, Geisbert TW, Broder CC. A Cross-Reactive Humanized Monoclonal Antibody Targeting Fusion Glycoprotein Function Protects Ferrets Against Lethal Nipah Virus and Hendra Virus Infection. The Journal of Infectious Diseases. PMID 31686101 DOI: 10.1093/infdis/jiz515  0.32
2019 Dang HV, Chan YP, Park YJ, Snijder J, Da Silva SC, Vu B, Yan L, Feng YR, Rockx B, Geisbert TW, Mire CE, Broder CC, Veesler D. An antibody against the F glycoprotein inhibits Nipah and Hendra virus infections. Nature Structural & Molecular Biology. PMID 31570878 DOI: 10.1038/s41594-019-0308-9  0.32
2019 Laing ED, Navaratnarajah CK, Cheliout Da Silva S, Petzing SR, Xu Y, Sterling SL, Marsh GA, Wang LF, Amaya M, Nikolov DB, Cattaneo R, Broder CC, Xu K. Structural and functional analyses reveal promiscuous and species specific use of ephrin receptors by Cedar virus. Proceedings of the National Academy of Sciences of the United States of America. PMID 31548390 DOI: 10.1073/pnas.1911773116  0.4
2019 Laing ED, Sterling SL, Weir DL, Beauregard CR, Smith IL, Larsen SE, Wang LF, Snow AL, Schaefer BC, Broder CC. Enhanced Autophagy Contributes to Reduced Viral Infection in Black Flying Fox Cells. Viruses. 11. PMID 30875748 DOI: 10.3390/v11030260  0.4
2018 Laing ED, Amaya M, Navaratnarajah CK, Feng YR, Cattaneo R, Wang LF, Broder CC. Rescue and characterization of recombinant cedar virus, a non-pathogenic Henipavirus species. Virology Journal. 15: 56. PMID 29587789 DOI: 10.1186/s12985-018-0964-0  0.4
2018 Laing ED, Mendenhall IH, Linster M, Low DHW, Chen Y, Yan L, Sterling SL, Borthwick S, Neves ES, Lim JSL, Skiles M, Lee BPY, Wang LF, Broder CC, Smith GJD. Serologic Evidence of Fruit Bat Exposure to Filoviruses, Singapore, 2011-2016. Emerging Infectious Diseases. 24: 114-117. PMID 29260678 DOI: 10.3201/eid2401.170401  0.4
2016 Mire CE, Satterfield BA, Geisbert JB, Agans KN, Borisevich V, Yan L, Chan YP, Cross RW, Fenton KA, Broder CC, Geisbert TW. Pathogenic Differences between Nipah Virus Bangladesh and Malaysia Strains in Primates: Implications for Antibody Therapy. Scientific Reports. 6: 30916. PMID 27484128 DOI: 10.1038/srep30916  0.92
2016 Broder CC, Weir DL, Reid PA. Hendra virus and Nipah virus animal vaccines. Vaccine. PMID 27154393 DOI: 10.1016/j.vaccine.2016.03.075  0.92
2016 Peel AJ, Field HE, Reid PA, Plowright RK, Broder CC, Skerratt LF, Hayman DT, Restif O, Taylor M, Martin G, Crameri G, Smith I, Baker M, Marsh GA, Barr J, et al. The equine Hendra virus vaccine remains a highly effective preventative measure against infection in horses and humans: 'The imperative to develop a human vaccine for the Hendra virus in Australia'. Infection Ecology & Epidemiology. 6: 31658. PMID 27151273  0.4
2016 Borisevich V, Lee B, Hickey A, DeBuysscher B, Broder CC, Feldmann H, Rockx B. Escape From Monoclonal Antibody Neutralization Affects Henipavirus Fitness In Vitro and In Vivo. The Journal of Infectious Diseases. 213: 448-55. PMID 26357909 DOI: 10.1093/infdis/jiv449  0.92
2015 Xu K, Chan YP, Bradel-Tretheway B, Akyol-Ataman Z, Zhu Y, Dutta S, Yan L, Feng Y, Wang LF, Skiniotis G, Lee B, Zhou ZH, Broder CC, Aguilar HC, Nikolov DB. Crystal Structure of the Pre-fusion Nipah Virus Fusion Glycoprotein Reveals a Novel Hexamer-of-Trimers Assembly. Plos Pathogens. 11: e1005322. PMID 26646856 DOI: 10.1371/journal.ppat.1005322  0.92
2014 Chowdhury S, Khan SU, Crameri G, Epstein JH, Broder CC, Islam A, Peel AJ, Barr J, Daszak P, Wang LF, Luby SP. Serological evidence of henipavirus exposure in cattle, goats and pigs in Bangladesh. Plos Neglected Tropical Diseases. 8: e3302. PMID 25412358 DOI: 10.1371/journal.pntd.0003302  0.92
2014 Geisbert TW, Mire CE, Geisbert JB, Chan YP, Agans KN, Feldmann F, Fenton KA, Zhu Z, Dimitrov DS, Scott DP, Bossart KN, Feldmann H, Broder CC. Therapeutic treatment of Nipah virus infection in nonhuman primates with a neutralizing human monoclonal antibody. Science Translational Medicine. 6: 242ra82. PMID 24964990 DOI: 10.1126/scitranslmed.3008929  0.92
2014 Quinnan GV, Onabajo O, Zhang P, Yan L, Mattapallil JJ, Zhang Z, Dong M, Lu M, Montefiori D, LaBranche C, Broder CC. Immunization of rabbits with highly purified, soluble, trimeric human immunodeficiency virus type 1 envelope glycoprotein induces a vigorous B cell response and broadly cross-reactive neutralization. Plos One. 9: e98060. PMID 24846288 DOI: 10.1371/journal.pone.0098060  0.92
2014 Weir DL, Laing ED, Smith IL, Wang LF, Broder CC. Host cell virus entry mediated by Australian bat lyssavirus G envelope glycoprotein occurs through a clathrin-mediated endocytic pathway that requires actin and Rab5. Virology Journal. 11: 40. PMID 24576301 DOI: 10.1186/1743-422X-11-40  0.92
2014 Middleton D, Pallister J, Klein R, Feng YR, Haining J, Arkinstall R, Frazer L, Huang JA, Edwards N, Wareing M, Elhay M, Hashmi Z, Bingham J, Yamada M, Johnson D, ... ... Broder CC, et al. Hendra virus vaccine, a one health approach to protecting horse, human, and environmental health. Emerging Infectious Diseases. 20: 372-9. PMID 24572697 DOI: 10.3201/eid2003.131159  0.92
2014 Weir DL, Annand EJ, Reid PA, Broder CC. Recent observations on Australian bat lyssavirus tropism and viral entry. Viruses. 6: 909-26. PMID 24556791 DOI: 10.3390/v6020909  0.92
2014 Mire CE, Geisbert JB, Agans KN, Feng YR, Fenton KA, Bossart KN, Yan L, Chan YP, Broder CC, Geisbert TW. A recombinant Hendra virus G glycoprotein subunit vaccine protects nonhuman primates against Hendra virus challenge. Journal of Virology. 88: 4624-31. PMID 24522928 DOI: 10.1128/JVI.00005-14  0.92
2014 McNabb L, Barr J, Crameri G, Juzva S, Riddell S, Colling A, Boyd V, Broder C, Wang LF, Lunt R. Henipavirus microsphere immuno-assays for detection of antibodies against Hendra virus. Journal of Virological Methods. 200: 22-8. PMID 24508193 DOI: 10.1016/j.jviromet.2014.01.010  0.92
2014 Elshabrawy HA, Fan J, Haddad CS, Ratia K, Broder CC, Caffrey M, Prabhakar BS. Identification of a broad-spectrum antiviral small molecule against severe acute respiratory syndrome coronavirus and Ebola, Hendra, and Nipah viruses by using a novel high-throughput screening assay. Journal of Virology. 88: 4353-65. PMID 24501399 DOI: 10.1128/JVI.03050-13  0.92
2014 Baker KS, Suu-Ire R, Barr J, Hayman DT, Broder CC, Horton DL, Durrant C, Murcia PR, Cunningham AA, Wood JL. Viral antibody dynamics in a chiropteran host. The Journal of Animal Ecology. 83: 415-28. PMID 24111634 DOI: 10.1111/1365-2656.12153  0.92
2014 Luby SP, Broder CC. Paramyxoviruses: Henipaviruses Viral Infections of Humans: Epidemiology and Control. 519-536. DOI: 10.1007/978-1-4899-7448-8_22  0.92
2013 Peel AJ, Sargan DR, Baker KS, Hayman DT, Barr JA, Crameri G, Suu-Ire R, Broder CC, Lembo T, Wang LF, Fooks AR, Rossiter SJ, Wood JL, Cunningham AA. Continent-wide panmixia of an African fruit bat facilitates transmission of potentially zoonotic viruses. Nature Communications. 4: 2770. PMID 24253424 DOI: 10.1038/ncomms3770  0.92
2013 Xu K, Rockx B, Xie Y, DeBuysscher BL, Fusco DL, Zhu Z, Chan YP, Xu Y, Luu T, Cer RZ, Feldmann H, Mokashi V, Dimitrov DS, Bishop-Lilly KA, Broder CC, et al. Crystal structure of the Hendra virus attachment G glycoprotein bound to a potent cross-reactive neutralizing human monoclonal antibody. Plos Pathogens. 9: e1003684. PMID 24130486 DOI: 10.1371/journal.ppat.1003684  0.92
2013 Bossart KN, Fusco DL, Broder CC. Paramyxovirus entry. Advances in Experimental Medicine and Biology. 790: 95-127. PMID 23884588 DOI: 10.1007/978-1-4614-7651-1_6  0.92
2013 Pallister JA, Klein R, Arkinstall R, Haining J, Long F, White JR, Payne J, Feng YR, Wang LF, Broder CC, Middleton D. Vaccination of ferrets with a recombinant G glycoprotein subunit vaccine provides protection against Nipah virus disease for over 12 months. Virology Journal. 10: 237. PMID 23867060 DOI: 10.1186/1743-422X-10-237  0.92
2013 Weir DL, Smith IL, Bossart KN, Wang LF, Broder CC. Host cell tropism mediated by Australian bat lyssavirus envelope glycoproteins. Virology. 444: 21-30. PMID 23849788 DOI: 10.1016/j.virol.2013.06.016  0.92
2013 Broder CC, Xu K, Nikolov DB, Zhu Z, Dimitrov DS, Middleton D, Pallister J, Geisbert TW, Bossart KN, Wang LF. A treatment for and vaccine against the deadly Hendra and Nipah viruses. Antiviral Research. 100: 8-13. PMID 23838047 DOI: 10.1016/j.antiviral.2013.06.012  0.92
2013 Peel AJ, McKinley TJ, Baker KS, Barr JA, Crameri G, Hayman DT, Feng YR, Broder CC, Wang LF, Cunningham AA, Wood JL. Use of cross-reactive serological assays for detecting novel pathogens in wildlife: assessing an appropriate cutoff for henipavirus assays in African bats. Journal of Virological Methods. 193: 295-303. PMID 23835034 DOI: 10.1016/j.jviromet.2013.06.030  0.92
2013 Broder CC. Passive immunization and active vaccination against hendra and nipah viruses Developments in Biologicals. 135: 125-138. PMID 23689890 DOI: 10.1159/000171017  0.92
2013 Zhu Z, Prabakaran P, Chen W, Broder CC, Gong R, Dimitrov DS. Human monoclonal antibodies as candidate therapeutics against emerging viruses and HIV-1. Virologica Sinica. 28: 71-80. PMID 23575729 DOI: 10.1007/s12250-013-3313-x  0.92
2013 Quinnan GV, Zhang P, Dong M, Chen H, Feng YR, Lewis M, Broder CC. Neutralizing antibody responses in macaques induced by human immunodeficiency virus type 1 monovalent or trivalent envelope glycoproteins. Plos One. 8: e59803. PMID 23533650 DOI: 10.1371/journal.pone.0059803  0.92
2013 Marsh GA, Virtue ER, Smith I, Todd S, Arkinstall R, Frazer L, Monaghan P, Smith GA, Broder CC, Middleton D, Wang LF. Recombinant Hendra viruses expressing a reporter gene retain pathogenicity in ferrets. Virology Journal. 10: 95. PMID 23521919 DOI: 10.1186/1743-422X-10-95  0.92
2013 Zhang G, Cowled C, Shi Z, Huang Z, Bishop-Lilly KA, Fang X, Wynne JW, Xiong Z, Baker ML, Zhao W, Tachedjian M, Zhu Y, Zhou P, Jiang X, Ng J, ... ... Broder CC, et al. Comparative analysis of bat genomes provides insight into the evolution of flight and immunity. Science (New York, N.Y.). 339: 456-60. PMID 23258410 DOI: 10.1126/science.1230835  0.92
2012 Stantchev TS, Paciga M, Lankford CR, Schwartzkopff F, Broder CC, Clouse KA. Cell-type specific requirements for thiol/disulfide exchange during HIV-1 entry and infection. Retrovirology. 9: 97. PMID 23206338 DOI: 10.1186/1742-4690-9-97  0.92
2012 Xu K, Chan YP, Rajashankar KR, Khetawat D, Yan L, Kolev MV, Broder CC, Nikolov DB. New insights into the Hendra virus attachment and entry process from structures of the virus G glycoprotein and its complex with Ephrin-B2. Plos One. 7: e48742. PMID 23144952 DOI: 10.1371/journal.pone.0048742  0.92
2012 Chan YP, Lu M, Dutta S, Yan L, Barr J, Flora M, Feng YR, Xu K, Nikolov DB, Wang LF, Skiniotis G, Broder CC. Biochemical, conformational, and immunogenic analysis of soluble trimeric forms of henipavirus fusion glycoproteins. Journal of Virology. 86: 11457-71. PMID 22915804 DOI: 10.1128/JVI.01318-12  0.92
2012 Bossart KN, Rockx B, Feldmann F, Brining D, Scott D, LaCasse R, Geisbert JB, Feng YR, Chan YP, Hickey AC, Broder CC, Feldmann H, Geisbert TW. A Hendra virus G glycoprotein subunit vaccine protects African green monkeys from Nipah virus challenge. Science Translational Medicine. 4: 146ra107. PMID 22875827 DOI: 10.1126/scitranslmed.3004241  0.92
2012 Kaku Y, Noguchi A, Marsh GA, Barr JA, Okutani A, Hotta K, Bazartseren B, Broder CC, Yamada A, Inoue S, Wang LF. Antigen capture ELISA system for henipaviruses using polyclonal antibodies obtained by DNA immunization. Archives of Virology. 157: 1605-9. PMID 22585045 DOI: 10.1007/s00705-012-1338-3  0.92
2012 Broder CC. Henipavirus outbreaks to antivirals: the current status of potential therapeutics. Current Opinion in Virology. 2: 176-87. PMID 22482714 DOI: 10.1016/j.coviro.2012.02.016  0.92
2012 Broder CC, Geisbert TW, Xu K, Nikolov DB, Wang LF, Middleton D, Pallister J, Bossart KN. Immunization strategies against henipaviruses. Current Topics in Microbiology and Immunology. 359: 197-223. PMID 22481140 DOI: 10.1007/82_2012_213  0.92
2012 Geisbert TW, Feldmann H, Broder CC. Animal challenge models of henipavirus infection and pathogenesis. Current Topics in Microbiology and Immunology. 359: 153-77. PMID 22476556 DOI: 10.1007/82_2012_208  0.92
2012 Steffen DL, Xu K, Nikolov DB, Broder CC. Henipavirus mediated membrane fusion, virus entry and targeted therapeutics. Viruses. 4: 280-308. PMID 22470837 DOI: 10.3390/v4020280  0.92
2012 Peel AJ, Baker KS, Crameri G, Barr JA, Hayman DT, Wright E, Broder CC, Fernández-Loras A, Fooks AR, Wang LF, Cunningham AA, Wood JL. Henipavirus neutralising antibodies in an isolated island population of African fruit bats. Plos One. 7: e30346. PMID 22253928 DOI: 10.1371/journal.pone.0030346  0.92
2012 Xu K, Broder CC, Nikolov DB. Ephrin-B2 and ephrin-B3 as functional henipavirus receptors. Seminars in Cell & Developmental Biology. 23: 116-23. PMID 22227101 DOI: 10.1016/j.semcdb.2011.12.005  0.92
2012 Colgrave ML, Snelling HJ, Shiell BJ, Feng YR, Chan YP, Bossart KN, Xu K, Nikolov DB, Broder CC, Michalski WP. Site occupancy and glycan compositional analysis of two soluble recombinant forms of the attachment glycoprotein of Hendra virus. Glycobiology. 22: 572-84. PMID 22171062 DOI: 10.1093/glycob/cwr180  0.92
2012 Kaku Y, Noguchi A, Marsh GA, Barr JA, Okutani A, Hotta K, Bazartseren B, Fukushi S, Broder CC, Yamada A, Inoue S, Wang LF. Second generation of pseudotype-based serum neutralization assay for Nipah virus antibodies: sensitive and high-throughput analysis utilizing secreted alkaline phosphatase. Journal of Virological Methods. 179: 226-32. PMID 22115786 DOI: 10.1016/j.jviromet.2011.11.003  0.92
2011 Bossart KN, Geisbert TW, Feldmann H, Zhu Z, Feldmann F, Geisbert JB, Yan L, Feng YR, Brining D, Scott D, Wang Y, Dimitrov AS, Callison J, Chan YP, Hickey AC, ... ... Broder CC, et al. A neutralizing human monoclonal antibody protects african green monkeys from hendra virus challenge. Science Translational Medicine. 3: 105ra103. PMID 22013123 DOI: 10.1126/scitranslmed.3002901  0.92
2011 Hayman DT, Wang LF, Barr J, Baker KS, Suu-Ire R, Broder CC, Cunningham AA, Wood JL. Antibodies to henipavirus or henipa-like viruses in domestic pigs in Ghana, West Africa. Plos One. 6: e25256. PMID 21966471 DOI: 10.1371/journal.pone.0025256  0.92
2011 Pallister J, Middleton D, Wang LF, Klein R, Haining J, Robinson R, Yamada M, White J, Payne J, Feng YR, Chan YP, Broder CC. A recombinant Hendra virus G glycoprotein-based subunit vaccine protects ferrets from lethal Hendra virus challenge. Vaccine. 29: 5623-30. PMID 21689706 DOI: 10.1016/j.vaccine.2011.06.015  0.92
2011 Yuan J, Marsh G, Khetawat D, Broder CC, Wang LF, Shi Z. Mutations in the G-H loop region of ephrin-B2 can enhance Nipah virus binding and infection. The Journal of General Virology. 92: 2142-52. PMID 21632558 DOI: 10.1099/vir.0.033787-0  0.92
2011 Celigoy J, Ramirez B, Tao L, Rong L, Yan L, Feng YR, Quinnan GV, Broder CC, Caffrey M. Probing the HIV gp120 envelope glycoprotein conformation by NMR. The Journal of Biological Chemistry. 286: 23975-81. PMID 21592971 DOI: 10.1074/jbc.M111.251025  0.92
2010 Chen W, Zhu Z, Liao H, Quinnan GV, Broder CC, Haynes BF, Dimitrov DS. Cross-Reactive Human IgM-Derived Monoclonal Antibodies that Bind to HIV-1 Envelope Glycoproteins. Viruses. 2: 547-565. PMID 21755021 DOI: 10.3390/v2020547  0.92
2010 Khurana B, Zhuang L, Moitra PK, Stantchev TS, Broder CC, Cutler ML, D'Arpa P. Human TOP1 residues implicated in species specificity of HIV-1 infection are required for interaction with BTBD2, and RNAi of BTBD2 in old world monkey and human cells increases permissiveness to HIV-1 infection. Virology Journal. 7: 332. PMID 21092135 DOI: 10.1186/1743-422X-7-332  0.92
2010 Khetawat D, Broder CC. A functional henipavirus envelope glycoprotein pseudotyped lentivirus assay system. Virology Journal. 7: 312. PMID 21073718 DOI: 10.1186/1743-422X-7-312  0.92
2010 Defang GN, Khetawat D, Broder CC, Quinnan GV. Induction of neutralizing antibodies to Hendra and Nipah glycoproteins using a Venezuelan equine encephalitis virus in vivo expression system. Vaccine. 29: 212-20. PMID 21050901 DOI: 10.1016/j.vaccine.2010.10.053  0.92
2010 Dube D, Schornberg KL, Shoemaker CJ, Delos SE, Stantchev TS, Clouse KA, Broder CC, White JM. Cell adhesion-dependent membrane trafficking of a binding partner for the ebolavirus glycoprotein is a determinant of viral entry. Proceedings of the National Academy of Sciences of the United States of America. 107: 16637-42. PMID 20817853 DOI: 10.1073/pnas.1008509107  0.92
2010 Rockx B, Bossart KN, Feldmann F, Geisbert JB, Hickey AC, Brining D, Callison J, Safronetz D, Marzi A, Kercher L, Long D, Broder CC, Feldmann H, Geisbert TW. A novel model of lethal Hendra virus infection in African green monkeys and the effectiveness of ribavirin treatment. Journal of Virology. 84: 9831-9. PMID 20660198 DOI: 10.1128/JVI.01163-10  0.92
2010 Geisbert TW, Daddario-DiCaprio KM, Hickey AC, Smith MA, Chan YP, Wang LF, Mattapallil JJ, Geisbert JB, Bossart KN, Broder CC. Development of an acute and highly pathogenic nonhuman primate model of Nipah virus infection. Plos One. 5: e10690. PMID 20502528 DOI: 10.1371/journal.pone.0010690  0.92
2010 Pietzsch J, Scheid JF, Mouquet H, Seaman MS, Broder CC, Nussenzweig MC. Anti-gp41 antibodies cloned from HIV-infected patients with broadly neutralizing serologic activity. Journal of Virology. 84: 5032-42. PMID 20219932 DOI: 10.1128/JVI.00154-10  0.92
2009 Bossart KN, Zhu Z, Middleton D, Klippel J, Crameri G, Bingham J, McEachern JA, Green D, Hancock TJ, Chan YP, Hickey AC, Dimitrov DS, Wang LF, Broder CC. A neutralizing human monoclonal antibody protects against lethal disease in a new ferret model of acute nipah virus infection. Plos Pathogens. 5: e1000642. PMID 19888339 DOI: 10.1371/journal.ppat.1000642  0.92
2009 Pallister J, Middleton D, Crameri G, Yamada M, Klein R, Hancock TJ, Foord A, Shiell B, Michalski W, Broder CC, Wang LF. Chloroquine administration does not prevent Nipah virus infection and disease in ferrets. Journal of Virology. 83: 11979-82. PMID 19759137 DOI: 10.1128/JVI.01847-09  0.92
2009 Blanco JC, Pletneva LM, Wieczorek L, Khetawat D, Stantchev TS, Broder CC, Polonis VR, Prince GA. Expression of Human CD4 and chemokine receptors in cotton rat cells confers permissiveness for productive HIV infection. Virology Journal. 6: 57. PMID 19442298 DOI: 10.1186/1743-422X-6-57  0.92
2009 Kaku Y, Noguchi A, Marsh GA, McEachern JA, Okutani A, Hotta K, Bazartseren B, Fukushi S, Broder CC, Yamada A, Inoue S, Wang LF. A neutralization test for specific detection of Nipah virus antibodies using pseudotyped vesicular stomatitis virus expressing green fluorescent protein. Journal of Virological Methods. 160: 7-13. PMID 19433112 DOI: 10.1016/j.jviromet.2009.04.037  0.92
2009 Chan YP, Yan L, Feng YR, Broder CC. Preparation of recombinant viral glycoproteins for novel and therapeutic antibody discovery. Methods in Molecular Biology (Clifton, N.J.). 525: 31-58, xiii. PMID 19252850 DOI: 10.1007/978-1-59745-554-1_2  0.92
2009 Dimitrova D, Choudhry V, Broder CC. Antibody fragment expression and purification. Methods in Molecular Biology (Clifton, N.J.). 525: 491-8, xiii. PMID 19252844 DOI: 10.1007/978-1-59745-554-1_25  0.92
2009 Prabakaran P, Zhu Z, Xiao X, Biragyn A, Dimitrov AS, Broder CC, Dimitrov DS. Potent human monoclonal antibodies against SARS CoV, Nipah and Hendra viruses. Expert Opinion On Biological Therapy. 9: 355-68. PMID 19216624 DOI: 10.1517/14712590902763755  0.92
2009 Hickey AC, Broder CC. The mechanism of henipavirus fusion: Examining the relationships between the attachment and fusion glycoproteins Virologica Sinica. 24: 110-120. DOI: 10.1007/s12250-009-3027-2  0.92
2008 Li Y, Wang J, Hickey AC, Zhang Y, Li Y, Wu Y, Zhang H, Yuan J, Han Z, McEachern J, Broder CC, Wang LF, Shi Z. Antibodies to Nipah or Nipah-like viruses in bats, China. Emerging Infectious Diseases. 14: 1974-6. PMID 19046545 DOI: 10.3201/eid1412.080359  0.92
2008 Patch JR, Han Z, McCarthy SE, Yan L, Wang LF, Harty RN, Broder CC. The YPLGVG sequence of the Nipah virus matrix protein is required for budding. Virology Journal. 5: 137. PMID 19000317 DOI: 10.1186/1743-422X-5-137  0.92
2008 Bishop KA, Hickey AC, Khetawat D, Patch JR, Bossart KN, Zhu Z, Wang LF, Dimitrov DS, Broder CC. Residues in the stalk domain of the hendra virus g glycoprotein modulate conformational changes associated with receptor binding. Journal of Virology. 82: 11398-409. PMID 18799571 DOI: 10.1128/JVI.02654-07  0.92
2008 Pavlin JA, Hickey AC, Ulbrandt N, Chan YP, Endy TP, Boukhvalova MS, Chunsuttiwat S, Nisalak A, Libraty DH, Green S, Rothman AL, Ennis FA, Jarman R, Gibbons RV, Broder CC. Human metapneumovirus reinfection among children in Thailand determined by ELISA using purified soluble fusion protein. The Journal of Infectious Diseases. 198: 836-42. PMID 18680407 DOI: 10.1086/591186  0.92
2008 Xu K, Rajashankar KR, Chan YP, Himanen JP, Broder CC, Nikolov DB. Host cell recognition by the henipaviruses: crystal structures of the Nipah G attachment glycoprotein and its complex with ephrin-B3. Proceedings of the National Academy of Sciences of the United States of America. 105: 9953-8. PMID 18632560 DOI: 10.1073/pnas.0804797105  0.92
2008 McEachern JA, Bingham J, Crameri G, Green DJ, Hancock TJ, Middleton D, Feng YR, Broder CC, Wang LF, Bossart KN. A recombinant subunit vaccine formulation protects against lethal Nipah virus challenge in cats. Vaccine. 26: 3842-52. PMID 18556094 DOI: 10.1016/j.vaccine.2008.05.016  0.92
2008 Zhang MY, Vu BK, Choudhary A, Lu H, Humbert M, Ong H, Alam M, Ruprecht RM, Quinnan G, Jiang S, Montefiori DC, Mascola JR, Broder CC, Haynes BF, Dimitrov DS. Cross-reactive human immunodeficiency virus type 1-neutralizing human monoclonal antibody that recognizes a novel conformational epitope on gp41 and lacks reactivity against self-antigens. Journal of Virology. 82: 6869-79. PMID 18480433 DOI: 10.1128/JVI.00033-08  0.92
2008 Dube D, Schornberg KL, Stantchev TS, Bonaparte MI, Delos SE, Bouton AH, Broder CC, White JM. Cell adhesion promotes Ebola virus envelope glycoprotein-mediated binding and infection. Journal of Virology. 82: 7238-42. PMID 18448524 DOI: 10.1128/JVI.00425-08  0.92
2008 Zhu Z, Bossart KN, Bishop KA, Crameri G, Dimitrov AS, McEachern JA, Feng Y, Middleton D, Wang LF, Broder CC, Dimitrov DS. Exceptionally potent cross-reactive neutralization of Nipah and Hendra viruses by a human monoclonal antibody. The Journal of Infectious Diseases. 197: 846-53. PMID 18271743 DOI: 10.1086/528801  0.92
2008 Bossart KN, Tachedjian M, McEachern JA, Crameri G, Zhu Z, Dimitrov DS, Broder CC, Wang LF. Functional studies of host-specific ephrin-B ligands as Henipavirus receptors. Virology. 372: 357-71. PMID 18054977 DOI: 10.1016/j.virol.2007.11.011  0.92
2007 Mungall BA, Middleton D, Crameri G, Halpin K, Bingham J, Eaton BT, Broder CC. Vertical transmission and fetal replication of Nipah virus in an experimentally infected cat. The Journal of Infectious Diseases. 196: 812-6. PMID 17703410 DOI: 10.1086/520818  0.92
2007 Zhang PF, Cham F, Dong M, Choudhary A, Bouma P, Zhang Z, Shao Y, Feng YR, Wang L, Mathy N, Voss G, Broder CC, Quinnan GV. Extensively cross-reactive anti-HIV-1 neutralizing antibodies induced by gp140 immunization. Proceedings of the National Academy of Sciences of the United States of America. 104: 10193-8. PMID 17540729 DOI: 10.1073/pnas.0608635104  0.92
2007 Bishop KA, Stantchev TS, Hickey AC, Khetawat D, Bossart KN, Krasnoperov V, Gill P, Feng YR, Wang L, Eaton BT, Wang LF, Broder CC. Identification of Hendra virus G glycoprotein residues that are critical for receptor binding. Journal of Virology. 81: 5893-901. PMID 17376907 DOI: 10.1128/JVI.02022-06  0.92
2007 Choudhry V, Zhang MY, Sidorov IA, Louis JM, Harris I, Dimitrov AS, Bouma P, Cham F, Choudhary A, Rybak SM, Fouts T, Montefiori DC, Broder CC, Quinnan GV, Dimitrov DS. Cross-reactive HIV-1 neutralizing monoclonal antibodies selected by screening of an immune human phage library against an envelope glycoprotein (gp140) isolated from a patient (R2) with broadly HIV-1 neutralizing antibodies. Virology. 363: 79-90. PMID 17306322 DOI: 10.1016/j.virol.2007.01.015  0.92
2007 Patch JR, Crameri G, Wang LF, Eaton BT, Broder CC. Quantitative analysis of Nipah virus proteins released as virus-like particles reveals central role for the matrix protein. Virology Journal. 4: 1. PMID 17204159 DOI: 10.1186/1743-422X-4-1  0.92
2007 Stantchev TS, Markovic I, Telford WG, Clouse KA, Broder CC. The tyrosine kinase inhibitor genistein blocks HIV-1 infection in primary human macrophages. Virus Research. 123: 178-89. PMID 17030448 DOI: 10.1016/j.virusres.2006.09.004  0.92
2007 Choudhry V, Zhang MY, Sidorov IA, Louis JM, Harris I, Dimitrov AS, Bouma P, Cham F, Choudhary A, Rybak SM, Fouts T, Montefiori DC, Broder CC, Quinnan GV, Dimitrov DS. Corrigendum to "Cross-reactive HIV-1 neutralizing monoclonal antibodies selected by screening of an immune human phage library against an envelope glycoprotein (gp140) isolated from a patient (R2) with broadly HIV-1 neutralizing antibodies" [Virology 363 (2007) 79-90] (DOI:10.1016/j.virol.2007.01.015) Virology. 368: 431. DOI: 10.1016/j.virol.2007.09.004  0.92
2006 Zhang MY, Choudhry V, Sidorov IA, Tenev V, Vu BK, Choudhary A, Lu H, Stiegler GM, Katinger HW, Jiang S, Broder CC, Dimitrov DS. Selection of a novel gp41-specific HIV-1 neutralizing human antibody by competitive antigen panning. Journal of Immunological Methods. 317: 21-30. PMID 17078964 DOI: 10.1016/j.jim.2006.09.016  0.92
2006 Mungall BA, Middleton D, Crameri G, Bingham J, Halpin K, Russell G, Green D, McEachern J, Pritchard LI, Eaton BT, Wang LF, Bossart KN, Broder CC. Feline model of acute nipah virus infection and protection with a soluble glycoprotein-based subunit vaccine. Journal of Virology. 80: 12293-302. PMID 17005664 DOI: 10.1128/JVI.01619-06  0.92
2006 Zhu Z, Dimitrov AS, Chakraborti S, Dimitrova D, Xiao X, Broder CC, Dimitrov DS. Development of human monoclonal antibodies against diseases caused by emerging and biodefense-related viruses. Expert Review of Anti-Infective Therapy. 4: 57-66. PMID 16441209 DOI: 10.1586/14787210.4.1.57  0.92
2006 Bossart KN, Broder CC. Developments towards effective treatments for Nipah and Hendra virus infection. Expert Review of Anti-Infective Therapy. 4: 43-55. PMID 16441208 DOI: 10.1586/14787210.4.1.43  0.92
2006 Zhu Z, Dimitrov AS, Bossart KN, Crameri G, Bishop KA, Choudhry V, Mungall BA, Feng YR, Choudhary A, Zhang MY, Feng Y, Wang LF, Xiao X, Eaton BT, Broder CC, et al. Potent neutralization of Hendra and Nipah viruses by human monoclonal antibodies. Journal of Virology. 80: 891-9. PMID 16378991 DOI: 10.1128/JVI.80.2.891-899.2006  0.92
2006 Eaton BT, Broder CC, Middleton D, Wang LF. Hendra and Nipah viruses: different and dangerous. Nature Reviews. Microbiology. 4: 23-35. PMID 16357858 DOI: 10.1038/nrmicro1323  0.92
2005 Eaton BT, Broder CC, Wang LF. Hendra and Nipah viruses: pathogenesis and therapeutics. Current Molecular Medicine. 5: 805-16. PMID 16375714 DOI: 10.2174/156652405774962308  0.92
2005 Bossart KN, Mungall BA, Crameri G, Wang LF, Eaton BT, Broder CC. Inhibition of Henipavirus fusion and infection by heptad-derived peptides of the Nipah virus fusion glycoprotein. Virology Journal. 2: 57. PMID 16026621 DOI: 10.1186/1743-422X-2-57  0.92
2005 Bonaparte MI, Dimitrov AS, Bossart KN, Crameri G, Mungall BA, Bishop KA, Choudhry V, Dimitrov DS, Wang LF, Eaton BT, Broder CC. Ephrin-B2 ligand is a functional receptor for Hendra virus and Nipah virus. Proceedings of the National Academy of Sciences of the United States of America. 102: 10652-7. PMID 15998730 DOI: 10.1073/pnas.0504887102  0.92
2005 Bossart KN, Crameri G, Dimitrov AS, Mungall BA, Feng YR, Patch JR, Choudhary A, Wang LF, Eaton BT, Broder CC. Receptor binding, fusion inhibition, and induction of cross-reactive neutralizing antibodies by a soluble G glycoprotein of Hendra virus. Journal of Virology. 79: 6690-702. PMID 15890907 DOI: 10.1128/JVI.79.11.6690-6702.2005  0.92
2005 Sloane AJ, Raso V, Dimitrov DS, Xiao X, Deo S, Muljadi N, Restuccia D, Turville S, Kearney C, Broder CC, Zoellner H, Cunningham AL, Bendall L, Lynch GW. Marked structural and functional heterogeneity in CXCR4: separation of HIV-1 and SDF-1alpha responses. Immunology and Cell Biology. 83: 129-43. PMID 15748209 DOI: 10.1111/j.1440-1711.2004.01304.x  0.92
2005 Quinnan GV, Yu XF, Lewis MG, Zhang PF, Sutter G, Silvera P, Dong M, Choudhary A, Sarkis PT, Bouma P, Zhang Z, Montefiori DC, Vancott TC, Broder CC. Protection of rhesus monkeys against infection with minimally pathogenic simian-human immunodeficiency virus: correlations with neutralizing antibodies and cytotoxic T cells. Journal of Virology. 79: 3358-69. PMID 15731230 DOI: 10.1128/JVI.79.6.3358-3369.2005  0.92
2004 Zhang MY, Xiao X, Sidorov IA, Choudhry V, Cham F, Zhang PF, Bouma P, Zwick M, Choudhary A, Montefiori DC, Broder CC, Burton DR, Quinnan GV, Dimitrov DS. Identification and characterization of a new cross-reactive human immunodeficiency virus type 1-neutralizing human monoclonal antibody. Journal of Virology. 78: 9233-42. PMID 15308718 DOI: 10.1128/JVI.78.17.9233-9242.2004  0.92
2004 Eaton BT, Wright PJ, Wang LF, Sergeyev O, Michalski WP, Bossart KN, Broder CC. Henipaviruses: recent observations on regulation of transcription and the nature of the cell receptor. Archives of Virology. Supplementum. 122-31. PMID 15119767  0.92
2004 Bossart KN, Broder CC. Viral glycoprotein-mediated cell fusion assays using vaccinia virus vectors. Methods in Molecular Biology (Clifton, N.J.). 269: 309-32. PMID 15114023 DOI: 10.1385/1-59259-789-0:309  0.92
2004 Markovic I, Stantchev TS, Fields KH, Tiffany LJ, Tomiç M, Weiss CD, Broder CC, Strebel K, Clouse KA. Thiol/disulfide exchange is a prerequisite for CXCR4-tropic HIV-1 envelope-mediated T-cell fusion during viral entry. Blood. 103: 1586-94. PMID 14592831 DOI: 10.1182/blood-2003-05-1390  0.92
2003 Zhang MY, Shu Y, Phogat S, Xiao X, Cham F, Bouma P, Choudhary A, Feng YR, Sanz I, Rybak S, Broder CC, Quinnan GV, Evans T, Dimitrov DS. Broadly cross-reactive HIV neutralizing human monoclonal antibody Fab selected by sequential antigen panning of a phage display library. Journal of Immunological Methods. 283: 17-25. PMID 14659896 DOI: 10.1016/j.jim.2003.07.003  0.92
2003 Xiao X, Phogat S, Shu Y, Phogat A, Chow YH, Wei OL, Goldstein H, Broder CC, Dimitrov DS. Purified complexes of HIV-1 envelope glycoproteins with CD4 and CCR5(CXCR4): production, characterization and immunogenicity. Vaccine. 21: 4275-84. PMID 14505910 DOI: 10.1016/S0264-410X(03)00494-8  0.92
2003 Albu DI, Jones-Trower A, Woron AM, Stellrecht K, Broder CC, Metzger DW. Intranasal vaccination using interleukin-12 and cholera toxin subunit B as adjuvants to enhance mucosal and systemic immunity to human immunodeficiency virus type 1 glycoproteins. Journal of Virology. 77: 5589-97. PMID 12719551 DOI: 10.1128/JVI.77.10.5589-5597.2003  0.92
2003 Dong M, Zhang PF, Grieder F, Lee J, Krishnamurthy G, VanCott T, Broder C, Polonis VR, Yu XF, Shao Y, Faix D, Valente P, Quinnan GV. Induction of primary virus-cross-reactive human immunodeficiency virus type 1-neutralizing antibodies in small animals by using an alphavirus-derived in vivo expression system. Journal of Virology. 77: 3119-30. PMID 12584337 DOI: 10.1128/JVI.77.5.3119-3130.2003  0.92
2002 Bossart KN, Wang LF, Flora MN, Chua KB, Lam SK, Eaton BT, Broder CC. Membrane fusion tropism and heterotypic functional activities of the Nipah virus and Hendra virus envelope glycoproteins. Journal of Virology. 76: 11186-98. PMID 12388678 DOI: 10.1128/JVI.76.22.11186-11198.2002  0.92
2002 Gallina A, Hanley TM, Mandel R, Trahey M, Broder CC, Viglianti GA, Ryser HJ. Inhibitors of protein-disulfide isomerase prevent cleavage of disulfide bonds in receptor-bound glycoprotein 120 and prevent HIV-1 entry. The Journal of Biological Chemistry. 277: 50579-88. PMID 12218051 DOI: 10.1074/jbc.M204547200  0.92
2002 Chow YH, Wei OL, Phogat S, Sidorov IA, Fouts TR, Broder CC, Dimitrov DS. Conserved structures exposed in HIV-1 envelope glycoproteins stabilized by flexible linkers as potent entry inhibitors and potential immunogens. Biochemistry. 41: 7176-82. PMID 12033952 DOI: 10.1021/bi025646d  0.92
2002 Moulard M, Phogat SK, Shu Y, Labrijn AF, Xiao X, Binley JM, Zhang MY, Sidorov IA, Broder CC, Robinson J, Parren PW, Burton DR, Dimitrov DS. Broadly cross-reactive HIV-1-neutralizing human monoclonal Fab selected for binding to gp120-CD4-CCR5 complexes. Proceedings of the National Academy of Sciences of the United States of America. 99: 6913-8. PMID 11997472 DOI: 10.1073/pnas.102562599  0.92
2001 Bossart KN, Wang LF, Eaton BT, Broder CC. Functional expression and membrane fusion tropism of the envelope glycoproteins of Hendra virus. Virology. 290: 121-35. PMID 11882997 DOI: 10.1006/viro.2001.1158  0.92
2001 Stantchev TS, Broder CC. Human immunodeficiency virus type-1 and chemokines: Beyond competition for common cellular receptors Cytokine and Growth Factor Reviews. 12: 219-243. PMID 11325604 DOI: 10.1016/S1359-6101(00)00033-2  0.92
2001 Earl PL, Sugiura W, Montefiori DC, Broder CC, Lee SA, Wild C, Lifson J, Moss B. Immunogenicity and protective efficacy of oligomeric human immunodeficiency virus type 1 gp140. Journal of Virology. 75: 645-53. PMID 11134278 DOI: 10.1128/JVI.75.2.645-653.2001  0.92
2000 Stantchev TS, Broder CC. Consistent and significant inhibition of human immunodeficiency virus type 1 envelope-mediated membrane fusion by β-chemokines (RANTES) in primary human macrophages Journal of Infectious Diseases. 182: 68-78. PMID 10882583 DOI: 10.1086/315700  0.92
2000 Chabot DJ, Broder CC. Substitutions in a homologous region of extracellular loop 2 of CXCR4 and CCR5 alter coreceptor activities for HIV-1 membrane fusion and virus entry. The Journal of Biological Chemistry. 275: 23774-82. PMID 10827088 DOI: 10.1074/jbc.M003438200  0.92
2000 Xiao X, Norwood D, Feng YR, Moriuchi M, Jones-Trower A, Stantchev TS, Moriuchi H, Broder CC, Dimitrov DS. Inefficient formation of a complex among CXCR4, CD4 and gp120 in U937 clones resistant to X4 gp120-gp41-mediated fusion. Experimental and Molecular Pathology. 68: 139-46. PMID 10816382 DOI: 10.1006/exmp.1999.2299  0.92
2000 Xiao X, Kinter A, Broder CC, Dimitrov DS. Interactions of CCR5 and CXCR4 with CD4 and gp120 in human blood monocyte-derived dendritic cells Experimental and Molecular Pathology. 68: 133-138. PMID 10816381 DOI: 10.1006/exmp.1999.2300  0.92
2000 Shirley L, Lapham CK, Chen H, King L, Manischewltz J, Romantseva T, Mostowski H, Stantchev TS, Broder CC, Golding H. Coreceptor competition for association with CD4 may change the susceptibility of human cells to infection with T-tropic and macrophagetropic isolates of human immunodeficiency virus type 1 Journal of Virology. 74: 5016-5023. PMID 10799575 DOI: 10.1128/JVI.74.11.5016-5023.2000  0.92
2000 Chabot DJ, Chen H, Dimitrov DS, Broder CC. N-linked glycosylation of CXCR4 masks coreceptor function for CCR5-dependent human immunodeficiency virus type 1 isolates. Journal of Virology. 74: 4404-13. PMID 10756055 DOI: 10.1128/JVI.74.9.4404-4413.2000  0.92
1999 Broder CC, Earl PL. Recombinant vaccinia viruses: Design, generation, and isolations Applied Biochemistry and Biotechnology - Part B Molecular Biotechnology. 13: 223-245. PMID 10934535 DOI: 10.1385/MB:13:3:223  0.92
1999 Chabot DJ, Zhang PF, Quinnan GV, Broder CC. Mutagenesis of CXCR4 identifies important domains for human immunodeficiency virus type 1 X4 isolate envelope-mediated membrane fusion and virus entry and reveals cryptic coreceptor activity for R5 isolates. Journal of Virology. 73: 6598-609. PMID 10400757  0.92
1999 Xiao X, Wu L, Stantchev TS, Feng YR, Ugolini S, Chen H, Shen Z, Riley JL, Broder CC, Sattentau QJ, Dimitrov DS. Constitutive cell surface association between CD4 and CCR5 Proceedings of the National Academy of Sciences of the United States of America. 96: 7496-7501. PMID 10377443 DOI: 10.1073/pnas.96.13.7496  0.92
1999 Dimitrov DS, Norwood D, Stantchev TS, Feng Y, Xiao X, Broder CC. A mechanism of resistance to HIV-1 entry: inefficient interactions of CXCR4 with CD4 and gp120 in macrophages. Virology. 259: 1-6. PMID 10364484 DOI: 10.1006/viro.1999.9747  0.92
1999 Golding H, Ouyang J, Zaitseva M, Broder CC, Dimitrov DS, Lapham C. Increased association of glycoprotein 120-CD4 with HIV type 1 coreceptors in the presence of complex-enhanced anti-CD4 monoclonal antibodies Aids Research and Human Retroviruses. 15: 149-159. PMID 10029247 DOI: 10.1089/088922299311574  0.92
1999 Sugiura W, Broder CC, Moss B, Earl PL. Characterization of conformation-dependent anti-gp120 murine monoclonal antibodies produced by immunization with monomeric and oligomeric human immunodeficiency virus type 1 envelope proteins. Virology. 254: 257-67. PMID 9986792 DOI: 10.1006/viro.1998.9549  0.92
1998 Dimitrov DS, Xiao X, Chabot DJ, Broder CC. HIV coreceptors. The Journal of Membrane Biology. 166: 75-90. PMID 9841733 DOI: 10.1007/s002329900450  0.92
1998 Wang JM, Ueda H, Howard OM, Grimm MC, Chertov O, Gong X, Gong W, Resau JH, Broder CC, Evans G, Arthur LO, Ruscetti FW, Oppenheim JJ. HIV-1 envelope gp120 inhibits the monocyte response to chemokines through CD4 signal-dependent chemokine receptor down-regulation. Journal of Immunology (Baltimore, Md. : 1950). 161: 4309-17. PMID 9780207  0.92
1998 Bazan HA, Alkhatib G, Broder CC, Berger EA. Patterns of CCR5, CXCR4, and CCR3 usage by envelope glycoproteins from human immunodeficiency virus type 1 primary isolates Journal of Virology. 72: 4485-4491. PMID 9557746  0.92
1997 Broder CC, Collman RG. Chemokine receptors and HIV Journal of Leukocyte Biology. 62: 20-29. PMID 9225988  0.92
1997 Lee S, Peden K, Dimitrov DS, Broder CC, Manischewitz J, Denisova G, Gershoni JM, Golding H. Enhancement of human immunodeficiency virus type 1 envelope-mediated fusion by a CD4-gp120 complex-specific monoclonal antibody Journal of Virology. 71: 6037-6043. PMID 9223495  0.92
1997 Broder CC, Earl PL. Design and construction of recombinant vaccinia viruses Methods in Molecular Biology (Clifton, N.J.). 62: 173-197. PMID 9108521  0.92
1997 Edinger AL, Amedee A, Miller K, Doranz BJ, Endres M, Sharron M, Samson M, Lu ZH, Clements JE, Murphey-Corb M, Peiper SC, Parmentier M, Broder CC, Doms RW. Differential utilization of CCR5 by macrophage and T cell tropic simian immunodeficiency virus strains. Proceedings of the National Academy of Sciences of the United States of America. 94: 4005-10. PMID 9108095 DOI: 10.1073/pnas.94.8.4005  0.92
1997 Earl PL, Broder CC, Doms RW, Moss B. Epitope map of human immunodeficiency virus type 1 gp41 derived from 47 monoclonal antibodies produced by immunization with oligomeric envelope protein Journal of Virology. 71: 2674-2684. PMID 9060620  0.92
1996 Broder CC, Dimitrov DS. HIV and the 7-transmembrane domain receptors Pathobiology. 64: 171-179. PMID 9031325  0.92
1996 Rucker J, Samson M, Doranz BJ, Libert F, Berson JF, Yi Y, Smyth RJ, Collman RG, Broder CC, Vassart G, Doms RW, Parmentier M. Regions in beta-chemokine receptors CCR5 and CCR2b that determine HIV-1 cofactor specificity. Cell. 87: 437-46. PMID 8898197 DOI: 10.1016/S0092-8674(00)81364-1  0.92
1996 Alkhatib G, Broder CC, Berger EA. Cell type-specific fusion cofactors determine human immunodeficiency virus type 1 tropism for T-cell lines versus primary macrophages Journal of Virology. 70: 5487-5494. PMID 8764060  0.92
1996 Alkhatib G, Combadiere C, Broder CC, Feng Y, Kennedy PE, Murphy PM, Berger EA. CC CKR5: A RANTES, MIP-1α, MIP-1β receptor as a fusion cofactor for macrophage-tropic HIV-1 Science. 272: 1955-1958. PMID 8658171  0.92
1996 Richardson TM, Stryjewski BL, Broder CC, Hoxie JA, Mascola JR, Earl PL, Doms RW. Humoral response to oligomeric human immunodeficiency virus type 1 envelope protein Journal of Virology. 70: 753-762. PMID 8551612  0.92
1996 Feng Y, Broder CC, Kennedy PA, Berger EA. HIV-1 entry cofactor: Functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor Pneumologie. 50: 572.  0.92
1995 Nussbaum O, Broder CC, Moss B, Stern LBL, Rozenblatt S, Berger EA. Functional and structural interactions between measles virus hemagglutinin and CD46 Journal of Virology. 69: 3341-3349. PMID 7745681  0.92
1995 Broder CC, Berger EA. Fusogenic selectivity of the envelope glycoprotein is a major determinant of human immunodeficiency virus type 1 tropism for CD4+ T-cell lines vs. primary macrophages Proceedings of the National Academy of Sciences of the United States of America. 92: 9004-9008. PMID 7568061 DOI: 10.1073/pnas.92.19.9004  0.92
1995 Golding H, Dimitrov DS, Manischewitz J, Broder CC, Robinson J, Fabian S, Littman DR, Lapham CK. Phorbol ester-induced down modulation of tailless CD4 receptors requires prior binding of gp120 and suggests a role for accessory molecules Journal of Virology. 69: 6140-6148. PMID 7545243  0.92
1994 Broder CC, Kennedy PE, Michaels F, Berger EA. Expression of foreign genes in cultured human primary macrophages using recombinant vaccinia virus vectors Gene. 142: 167-174. PMID 8194748 DOI: 10.1016/0378-1119(94)90257-7  0.92
1994 Nussbaum O, Broder CC, Berger EA. Fusogenic mechanisms of enveloped-virus glycoproteins analyzed by a novel recombinant vaccinia virus-based assay quantitating cell fusion-dependent reporter gene activation Journal of Virology. 68: 5411-5422. PMID 8057423  0.92
1994 Broder CC, Earl PL, Long D, Abedon ST, Moss B, Doms RW. Antigenic implications of human immunodeficiency virus type 1 envelope quaternary structure: Oligomer-specific and -sensitive monoclonal antibodies Proceedings of the National Academy of Sciences of the United States of America. 91: 11699-11703. PMID 7972127 DOI: 10.1073/pnas.91.24.11699  0.92
1994 Earl PL, Broder CC, Long D, Lee SA, Peterson J, Chakrabarti S, Doms RW, Moss B. Native oligomeric human immunodeficiency virus type 1 envelope glycoprotein elicits diverse monoclonal antibody reactivities Journal of Virology. 68: 3015-3026. PMID 7512157  0.92
1993 Broder CC, Dimitrov DS, Blumenthal R, Berger EA. The block to HIV-1 envelope glycoprotein-mediated membrane fusion in animal cells expressing human CD4 can be overcome by a human cell component(s) Virology. 193: 483-491. PMID 8438583 DOI: 10.1006/viro.1993.1151  0.92
1993 Dimitrov DS, Broder CC, Berger EA, Blumenthal R. Calcium ions are required for cell fusion mediated by the CD4-human immunodeficiency virus type 1 envelope glycoprotein interaction Journal of Virology. 67: 1647-1652. PMID 8437234  0.92
1993 Broder CC, Berger EA. CD4 molecules with a diversity of mutations encompassing the CDR3 region efficiently support human immunodeficiency virus type 1 envelope glycoprotein-mediated cell fusion Journal of Virology. 67: 913-926. PMID 8419649  0.92
1992 Lottenberg R, Broder CC, Boyle MD, Kain SJ, Schroeder BL, Curtiss R. Cloning, sequence analysis, and expression in Escherichia coli of a streptococcal plasmin receptor. Journal of Bacteriology. 174: 5204-10. PMID 1322883  0.92
1991 Mc Coy HE, Broder CC, Lottenberg R. Streptokinases produced by pathogenic group c streptococci demonstrate species-specific plasminogen activation Journal of Infectious Diseases. 164: 515-521. PMID 1869838 DOI: 10.1093/infdis/164.3.515  0.92
1991 Broder CC, Lottenberg R, Von Mering GO, Johnston KH, Boyle MDP. Isolation of a prokaryotic plasmin receptor: Relationship to a plasminogen activator produced by the same micro-organism Journal of Biological Chemistry. 266: 4922-4928. PMID 1848229  0.92
1989 Broder CC, Lottenberg R, Boyle MDP. Mapping of the human plasmin domain recognized by the unique plasmin receptor of group A streptococci Infection and Immunity. 57: 2597-2605. PMID 2547717  0.92
1987 Lottenberg R, Broder CC, Boyle MD. Identification of a specific receptor for plasmin on a group A streptococcus Infection and Immunity. 55: 1914-1918. PMID 3038753  0.92
Show low-probability matches.